NCT00064259 2021-02-17A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction CancerNational Cancer Institute (NCI)Phase 1/2 Terminated15 enrolled 5 charts